Skip to Main Content

Advertisement

Skip Nav Destination

Tasigna for Chronic and Accelerated Phase Philadelphia Chromosome–Positive Chronic Myelogenous Leukemia Resistant to or Intolerant of Imatinib

Clin Cancer Res (2008) 14 (17): 5325–5331.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • Vincenzo Costanzo
  • Yashwant Kumar Ratre
  • Emanuela Andretta
  • Rakesh Acharya
  • L. V. K. S. Bhaskar
  • Henu Kumar Verma
Current Treatment Options in Oncology (2024) 25 (4): 465.
  • Arzu Zeynep Karabay
  • Tulin Ozkan
  • Asli Koc
  • Yalda Hekmatshoar
  • A. Selen Gurkan-Alp
  • Asuman Sunguroglu
Toxicology in Vitro (2024) 95: 105754.
  • Louisa Pechlivani
  • Nikoleta Ntemou
  • Despoina Pantazi
  • Dimitrios Alivertis
  • Konstantinos Skobridis
  • Alexandros D. Tselepis
Pharmaceuticals (2024) 17 (3): 349.
  • Robert D. Schwab
  • Selina M. Luger
Current Treatment Options in Oncology (2023) 24 (7): 757.
  • Ritika Khivansara
  • Sandhya Jadhav
  • Maheshkumar Borkar
  • Atul Sherje
Current Analytical Chemistry (2023) 19 (7): 513.
  • Meng Wang
  • Yifang Zhu
  • Ming Huang
  • Hao Wang
  • Wenjia Zhou
  • Dan Lu
  • Quanying Zhang
Clinical Pharmacology in Drug Development (2022) 11 (10): 1233.
  • Veerandra Kumar
  • Priyanka Singh
  • Sonu Kumar Gupta
  • Villayat Ali
  • Malkhey Verma
Molecular and Cellular Biochemistry (2022) 477 (4): 1261.
  • Peter Kim
  • Luke Masha
  • Amanda Olson
  • Cezar Iliescu
  • Kaveh Karimzad
  • Saamir Hassan
  • Nicolas Palaskas
  • Jean-Bernard Durand
  • Cheuk Hong Leung
  • Juan Lopez-Mattei
Frontiers in Cardiovascular Medicine (2021) 8
  • Emanuela Andretta
  • Caterina Costa
  • Consiglia Longobardi
  • Sara Damiano
  • Antonio Giordano
  • Francesco Pagnini
  • Serena Montagnaro
  • Massimiliano Quintiliani
  • Chiara Lauritano
  • Roberto Ciarcia
Frontiers in Oncology (2021) 11
  • Theodore P. Braun
  • Christopher A. Eide
  • Brian J. Druker
Cancer Cell (2020) 37 (4): 530.
  • Hong-Liang Lin
  • Ling-Chun Chen
  • Wen-Ting Cheng
  • Wei-Jie Cheng
  • Hsiu-O Ho
  • Ming-Thau Sheu
Pharmaceutics (2020) 12 (2): 137.
  • E. Dianne Pulte
  • Tanya Wroblewski
  • Erik Bloomquist
  • Shenghui Tang
  • Ann Farrell
  • Albert Deisseroth
  • Amy E. McKee
  • Richard Pazdur
The Oncologist (2019) 24 (5): e188.
  • Junghoon Shin
  • Youngil Koh
  • Seo Hyun Yoon
  • Joo‐Youn Cho
  • Dae‐Young Kim
  • Kyoo‐Hyung Lee
  • Hyeong‐Joon Kim
  • Jae‐Sook Ahn
  • Yeo‐Kyeoung Kim
  • Jinny Park
  • Sang‐Kyun Sohn
  • Joon Ho Moon
  • Yoo Jin Lee
  • Seonghae Yoon
  • Jeong‐Ok Lee
  • June‐Won Cheong
  • Kyoung Ha Kim
  • Sung‐Hyun Kim
  • Hoon‐Gu Kim
  • Hawk Kim
  • Seung‐Hyun Nam
  • Young Rok Do
  • Sang‐Gon Park
  • Seong Kyu Park
  • Sung Hwa Bae
  • Hun Ho Song
  • Dong‐Yeop Shin
  • Doyeun Oh
  • Min Kyoung Kim
  • Chul Won Jung
  • Seonyang Park
  • Inho Kim
Cancer Medicine (2018) 7 (5): 1814.
  • Xianbin Tian
  • Hefei Zhang
  • Tycho Heimbach
  • Handan He
  • Aby Buchbinder
  • Mary Aghoghovbia
  • Florence Hourcade‐Potelleret
The Journal of Clinical Pharmacology (2018) 58 (12): 1533.
  • Yaakov Cass
  • Thomas H Connor
  • Alexander Tabachnik
Journal of Oncology Pharmacy Practice (2017) 23 (5): 350.
  • Andrew Rowland
  • Madelé van Dyk
  • Arduino A. Mangoni
  • John O. Miners
  • Ross A. McKinnon
  • Michael D. Wiese
  • Angela Rowland
  • Ganessan Kichenadasse
  • Howard Gurney
  • Michael J. Sorich
Expert Opinion on Drug Metabolism & Toxicology (2017) 13 (1): 31.
  • Toshiki Yamada
  • Yasuhito Nannya
  • Masahito Shimizu
  • Mitsuru Seishima
  • Hisashi Tsurumi
Internal Medicine (2016) 55 (23): 3495.
  • Simona Soverini
  • Michele Baccarani
  • Giovanni Martinelli
The Lancet Haematology (2016) 3 (12): e554.
  • D. LEKES
  • I. SZADVARI
  • O. KRIZANOVA
  • K. LOPUSNA
  • I. REZUCHOVA
  • M. NOVAKOVA
  • Z. NOVAKOVA
  • T. PARAK
  • P. BABULA
Physiological Research S505.
  • Michael O’Donnell
  • Jean-Damien Charrier
Tetrahedron Letters (2016) 57 (17): 1882.
  • J L Steegmann
  • M Baccarani
  • M Breccia
  • L F Casado
  • V García-Gutiérrez
  • A Hochhaus
  • D-W Kim
  • T D Kim
  • H J Khoury
  • P Le Coutre
  • J Mayer
  • D Milojkovic
  • K Porkka
  • D Rea
  • G Rosti
  • S Saussele
  • R Hehlmann
  • R E Clark
Leukemia (2016) 30 (8): 1648.
  • Wu Luo
  • Li Song
  • Xi-Lei Chen
  • Xiang-Feng Zeng
  • Jian-Zhang Wu
  • Cai-Rong Zhu
  • Tao Huang
  • Xiang-Peng Tan
  • Xiao-Mian Lin
  • Qi Yang
  • Ji-Zhong Wang
  • Xiao-Kun Li
  • Xiao-Ping Wu
Oncotarget (2016) 7 (18): 26709.
  • Hefei Zhang
  • Jennifer Sheng
  • Jin H. Ko
  • Cheng Zheng
  • Wei Zhou
  • Petra Priess
  • Wen Lin
  • Steven Novick
The Journal of Clinical Pharmacology (2015) 55 (4): 401.
  • Masatomo Miura
Biological & Pharmaceutical Bulletin (2015) 38 (5): 645.
  • Henry J. Henk
  • Mabel Woloj
  • Mark Shapiro
  • Jennifer Whiteley
Clinical Therapeutics (2015) 37 (1): 124.
  • Rosie A. Johnston
  • Tristan Rawling
  • Ting Chan
  • Fanfan Zhou
  • Michael Murray
Drug Metabolism and Disposition (2014) 42 (11): 1851.
  • Josep Darbà
  • Lisette Kaskens
  • Manuel Abecassis
  • Joao Carrasco
  • Ricardo Vitorino
  • Matthew Taylor
PharmacoEconomics Spanish Research Articles (2014) 11 (3): 73.
  • Peter Y. Kim
  • Michael S. Ewer
Current Treatment Options in Cardiovascular Medicine (2014) 16 (5)
  • Maiko Abumiya
  • Naoto Takahashi
  • Takenori Niioka
  • Yoshihiro Kameoka
  • Naohito Fujishima
  • Hiroyuki Tagawa
  • Kenichi Sawada
  • Masatomo Miura
Drug Metabolism and Pharmacokinetics (2014) 29 (6): 449.
  • Venkateswaran C. Pillai
  • Robert A. Parise
  • Susan M. Christner
  • Michelle A. Rudek
  • Jan H. Beumer
  • Raman Venkataramanan
The Journal of Clinical Pharmacology (2014) 54 (11): 1272.
  • Takashi Shibata
  • Yosuke Minami
  • Ayako Mitsuma
  • Sachi Morita
  • Megumi Inada-Inoue
  • Tomoyo Oguri
  • Tomoya Shimokata
  • Mihoko Sugishita
  • Tomoki Naoe
  • Yuichi Ando
International Journal of Clinical Oncology (2014) 19 (2): 391.
  • Jie Shao
  • John S. Markowitz
  • Di Bei
  • Guohua An
Journal of Pharmaceutical Sciences (2014) 103 (12): 3810.
  • James D. Griffin
  • Annie Guerin
  • Lei Chen
  • Alexander R. Macalalad
  • Jiayuan Luo
  • Raluca Ionescu-Ittu
  • Eric Qiong Wu
Current Medical Research and Opinion (2013) 29 (6): 623.
  • Pratap Neelakantan
  • Jane F Apperley
Clinical Practice (2013) 10 (3): 283.
  • Petr Kosztyu
  • Petr Dolezel
  • Petr Mlejnek
Pharmacological Research (2013) 67 (1): 79.
  • Debra H. Josephs
  • Danielle S. Fisher
  • James Spicer
  • Robert J. Flanagan
Therapeutic Drug Monitoring (2013) 35 (5): 562.
  • Laura N. Eadie
  • Verity A. Saunders
  • Timothy P. Hughes
  • Deborah L. White
Leukemia & Lymphoma (2013) 54 (3): 569.
  • Michael R. Savona
  • Giuseppe Saglio
Acta Haematologica (2013) 130 (4): 268.
  • Samuel Aparicio
  • Carlos Caldas
New England Journal of Medicine (2013) 368 (9): 842.
  • Ophelia Q. P. Yin
  • Véronique Bédoucha
  • Tracey McCulloch
  • Cheng Zheng
  • Wei Zhou
  • Azra Hussaini
  • Steven Novick
Cancer Chemotherapy and Pharmacology (2013) 71 (1): 219.
  • Shuichi Ota
  • Kiyotoshi Imai
  • Takahide Ara
  • Reiki Ogasawara
  • Koichiro Minauchi
  • Teiichi Hirano
  • Masahiro Ogasawara
  • Yoshio Kiyama
  • Naoki Kobayashi
  • Masahiro Imamura
Journal of Hematopoietic Cell Transplantation (2013) 2 (2): 56.
  • Avisek Deyati
  • Erfan Younesi
  • Martin Hofmann-Apitius
  • Natalia Novac
Drug Discovery Today (2013) 18 (13-14): 614.
  • Simona Soverini
  • Giovanni Martinelli
  • Gianantonio Rosti
  • Ilaria Iacobucci
  • Michele Baccarani
Pharmacogenomics (2012) 13 (11): 1271.
  • F J Giles
  • H M Kantarjian
  • P D le Coutre
  • M Baccarani
  • F-X Mahon
  • R E Blakesley
  • N J Gallagher
  • K Gillis
  • S L Goldberg
  • R A Larson
  • A Hochhaus
  • O G Ottmann
Leukemia (2012) 26 (5): 959.
Close Modal

or Create an Account

Close Modal
Close Modal